|
Boston Business Journal Names NxStage®
Medical Third Fastest Growing Company in Massachusetts
LAWRENCE, Mass., Oct. 1 /PRNewswire-FirstCall/ --NxStage
Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of
innovative dialysis products, today announced that it has been
recognized as the No. 3 Fastest Growing Company in Massachusetts
by the Boston Business Journal. This is the third consecutive
year that NxStage has been recognized by the Boston Business
Journal as one of the fastest growing companies for its list,
which this year ranks the "Fastest Growing Public Companies" by
revenue growth from 2006 to 2008.
"We are pleased to be recognized by the Boston Business Journal
for the rapid growth we have achieved as an innovative, market
pioneer," said Jeffrey H. Burbank, Founder and Chief Executive
Officer of NxStage Medical, Inc. "Our growth can be attributed,
in part, to our continued efforts in developing the home
hemodialysis market with the industry's only portable,
easy-to-use home hemodialysis machine - the NxStage System
One(TM), and our market share gains within the critical care
market. We also further strengthened our revenue base through
the strategic acquisition of Medisystems®, our in-center
business, in late 2007."
The NxStage System One is the first truly portable hemodialysis
system cleared for home use by the U.S. Food & Drug
Administration. Its simplicity and compact size are intended to
allow ease-of-use and to give patients the opportunity to travel
with their therapy with their doctor's approval. It plugs into
standard electrical outlets and, unlike conventional
hemodialysis systems, requires no special infrastructure to
operate. Under the guidance of their physician, patients can use
the NxStage System One, with their trained partners, where, how
and when it best meets their needs, at home or on vacation.
In 2009, NxStage broadened access to its dialysis products
beyond the United States for the first time through a
distribution agreement that brought the NxStage System One to
the U.K. and Ireland. The Company also formed a strategic
business alliance with Asahi Kasei Kuraray Medical, a leading
medical supply company in Japan.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device
company, headquartered in Lawrence, Massachusetts, USA, that
develops, manufactures and markets innovative products for the
treatment of end stage renal disease and acute kidney failure.
For more information on NxStage and its products, please visit
the company's website at
http://www.nxstage.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
All statements contained in this release that are not clearly
historical in nature are forward-looking, and the words
"anticipate," "believe," "expect," "estimate," "plan," and
similar expressions are generally intended to identify
forward-looking statements. Actual results may differ materially
from those indicated by these forward-looking statements as a
result of various important factors including, but not limited
to, changes relating to customer demand for NxStage's System One
and other products, changes in market adoption of home daily
hemodialysis, market adoption for the System One and other
products internationally, and other factors that are discussed
in NxStage's filings with the Securities and Exchange
Commission, including the Quarterly Report on Form 10-Q for the
quarter ended June 30, 2009. NxStage is under no obligation to
(and expressly disclaims any such obligation to) update or alter
its forward-looking statements, whether as a result of new
information, future events or otherwise.
Contact
Kristen K. Sheppard, Esq.
VP, Investor Relations
ksheppard @nxstage.com
Source
NxStage Medical, Inc.
|
